Jenburkt Pharma Live Share Price Today, Share Analysis and Chart

Name: Jenburkt Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Jenburkt Pharmaceuticals Ltd.
Rating: 2.705416625
Author: Trendlyne DVM scores

Mid-range Performer

about

Jenburkt Pharmaceuticals is in the business of manufacturing, producing, developing and marketing a wide range of branded Pharmaceuticals and health care products. (Source : 202503 Annual Report Page No: 57)

1088.95 -0.85 (-0.08%)

BSE Volume

BSE 01 Jan, 2026 11:59 AM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

40.6 / 100

Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM

No estimates available

Jenburkt Pharma Live Price Chart

Loading Fundamental data..

Loading data..

Is Jenburkt Pharmaceuticals Ltd. worth buying?

29 Votes:

Buy 65.52%

Sell 20.69%

Hold 13.79%

Jenburkt Pharma Live Share Price Today, Share Analysis and Chart

Jenburkt Pharmaceuticals is in the business of manufacturing, producing, developing and marketing a wide range of branded Pharmaceuticals and health care products. (Source : 202503 Annual Report Page No: 57)

SWOT Analysis

Jenburkt Pharma Live Price Chart